Trial Profile
A Single-center Experience of five consecutive pediatric patients Affected by Hepatocellular Carcinoma who were treated with bevacizumab along with conventional platinum-based chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 26 Oct 2017 New trial record